These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27888435)

  • 1. Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial.
    Strollo R; Soare A; Manon Khazrai Y; Di Mauro A; Palermo A; Del Toro R; Fallucca S; Giovanna Belluomo M; Dugo L; Pianesi M; Pozzilli P; Napoli N
    Endocrine; 2017 Jun; 56(3):667-674. PubMed ID: 27888435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
    Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults.
    Napoli N; Strollo R; Defeudis G; Leto G; Moretti C; Zampetti S; D'Onofrio L; Campagna G; Palermo A; Greto V; Manfrini S; Hawa MI; Leslie RD; Pozzilli P; Buzzetti R;
    J Clin Endocrinol Metab; 2018 May; 103(5):1921-1928. PubMed ID: 29506222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus.
    Pereira M; Gohin S; Lund N; Hvid A; Smitham PJ; Oddy MJ; Reichert I; Farlay D; Roux JP; Cleasby ME; Chenu C
    Osteoporos Int; 2017 Jan; 28(1):309-320. PubMed ID: 27468901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
    Gennari L; Merlotti D; Valenti R; Ceccarelli E; Ruvio M; Pietrini MG; Capodarca C; Franci MB; Campagna MS; Calabrò A; Cataldo D; Stolakis K; Dotta F; Nuti R
    J Clin Endocrinol Metab; 2012 May; 97(5):1737-44. PubMed ID: 22399511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.
    Armamento-Villareal R; Sadler C; Napoli N; Shah K; Chode S; Sinacore DR; Qualls C; Villareal DT
    J Bone Miner Res; 2012 May; 27(5):1215-21. PubMed ID: 22392834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
    van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
    J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
    Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
    Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
    García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
    Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
    Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diets higher in dairy foods and dietary protein support bone health during diet- and exercise-induced weight loss in overweight and obese premenopausal women.
    Josse AR; Atkinson SA; Tarnopolsky MA; Phillips SM
    J Clin Endocrinol Metab; 2012 Jan; 97(1):251-60. PubMed ID: 22049177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.
    Hygum K; Starup-Linde J; Harsløf T; Vestergaard P; Langdahl BL
    Eur J Endocrinol; 2017 Mar; 176(3):R137-R157. PubMed ID: 28049653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss-induced alterations in serum markers of bone turnover persist during weight maintenance in obese men and women.
    Hinton PS; LeCheminant JD; Smith BK; Rector RS; Donnelly JE
    J Am Coll Nutr; 2009 Oct; 28(5):565-73. PubMed ID: 20439552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bariatric Roux-En-Y Gastric Bypass Surgery: Adipocyte Proteins Involved in Increased Bone Remodeling in Humans.
    Biagioni MFG; Mendes AL; Nogueira CR; Leite CV; Gollino L; Mazeto GM
    Obes Surg; 2017 Jul; 27(7):1789-1796. PubMed ID: 28091892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin levels and changes in bone metabolism after bariatric surgery.
    Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
    J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover.
    Yavropoulou MP; van Lierop AH; Hamdy NA; Rizzoli R; Papapoulos SE
    Bone; 2012 Jul; 51(1):153-7. PubMed ID: 22579776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of weight loss on body composition, serum bone markers, and adipokines in prepubertal obese children after 1-year intervention.
    Gajewska J; Ambroszkiewicz J; Klemarczyk W; Chełchowska M; Weker H; Szamotulska K
    Endocr Res; 2018 May; 43(2):80-89. PubMed ID: 29192796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.